Skip to main content

Lipton Lab

 

Lab Personnel


Overview

Dr. Lipton is mainly focused on unit, college, and university-based initiatives to: (1) support researchers in translating research into practice for neurodegenerative disease, (2) develop programs that improve researcher performance using data-driven metrics, and (3) create new processes that allow scholars to focus on their research rather than administrivia, which often takes faculty away from mission-critical work.

However, Dr. Lipton still provides expertise and serves as a co-investigator for neuroscience-based research projects, locally and across the nation. As a neuropharmacologist by training, his areas of technical emphasis have been neurotransmitter and drug quantitation by High Performance Liquid Chromatography. His research has been split between (1) the consequences of prenatal exposure to drugs of abuse on the dopamine system and (2) the etiology of, and the development of experimental therapeutics for Parkinson’s disease. He has over 35 years of expertise in analytical biochemistry, specializing in monoamines, and continues to directly carry out this work in the laboratory in support of several projects.